Persistently increased systemic, but not cardiac-specific, adhesion molecule expression and coronary endothelial dysfunction in human cardiac allografts.

[1]  P. Guiteras,et al.  Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation. , 2001, The Journal of thoracic and cardiovascular surgery.

[2]  K. Lemström,et al.  Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat. , 1997, Circulation.

[3]  D. Perkins,et al.  The Allograft Defines the Type of Rejection (Acute versus Chronic) in the Face of an Established Effector Immune Response1 , 2004, The Journal of Immunology.

[4]  P. Ridker,et al.  Soluble P-Selectin and the Risk of Future Cardiovascular Events , 2001, Circulation.

[5]  L. Klein,et al.  Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  D. Wagner,et al.  Adhesion molecules--Part 1. , 1996, The New England journal of medicine.

[7]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[8]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[9]  D. Tanné,et al.  Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. , 2002, Journal of the American College of Cardiology.

[10]  H. Valantine.  Cardiac allograft vasculopathy after heart transplantation: risk factors and management. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  K. Ley,et al.  Role of platelets in the development of atherosclerosis. , 2004, Trends in cardiovascular medicine.

[12]  J. A. Conner,et al.  Value of Serum-Soluble Intercellular Adhesion Molecule-1 for the Noninvasive Risk Assessment of Transplant Coronary Artery Disease, Posttransplant Ischemic Events, and Cardiac Graft Failure , 2000, Circulation.

[13]  A. Haverich,et al.  Systemic Inflammatory Response in Cardiac Allograft Vasculopathy: High-Sensitive C-Reactive Protein Is Associated With Progressive Luminal Obstruction , 2000, Circulation.

[14]  J. Hodgson,et al.  Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. , 1989, Circulation.

[15]  J. Keaney,et al.  The clinical implications of endothelial dysfunction. , 2003, Journal of the American College of Cardiology.

[16]  S. Verma,et al.  Endothelial function testing as a biomarker of vascular disease. , 2003, Circulation.

[17]  S. Blankenberg,et al.  Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.

[18]  Andreas Schober,et al.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E , 2003, Nature Medicine.

[19]  E. Boerwinkle,et al.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. , 1997, Circulation.

[20]  S. Blankenberg,et al.  Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease , 2001, Circulation.

[21]  B. Reichart,et al.  Expression of Endomyocardial Nitric Oxide Synthase and Coronary Endothelial Function in Human Cardiac Allografts , 2001, Circulation.

[22]  P. Ridker,et al.  Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men , 1998, The Lancet.

[23]  K. Ley.  The role of selectins in inflammation and disease. , 2003, Trends in molecular medicine.

[24]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[25]  S. Fujimoto,et al.  Weibel-Palade Body , 1989 .

[26]  D. Wagner.  The Weibel-Palade Body: the Storage Granule for von Willebrand Factor and P-selectin , 1993, Thrombosis and Haemostasis.

[27]  P. Kubes,et al.  Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. , 1995, The Journal of clinical investigation.

[28]  Gregory Y H Lip,et al.  The adhesion molecule P-selectin and cardiovascular disease. , 2003, European heart journal.